Exploring factors influencing uptake and adherence to a home-based prehabilitation physical activity and exercise intervention for patients undergoing chemotherapy before major surgery (ChemoFit): a qualitative study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
22 09 2022
Historique:
entrez: 22 9 2022
pubmed: 23 9 2022
medline: 28 9 2022
Statut: epublish

Résumé

Preoperative exercise training can improve cardiorespiratory fitness before major surgery. However, little is known about what influences participation and adherence in high-risk patient groups. We identified barriers and facilitators to uptake, engagement and adherence to a presurgical, home-based physical activity and exercise intervention called ChemoFit delivered during chemotherapy and before major oesophagogastric surgery. A qualitative study using focus group discussions and individual semi-structured interviews was conducted. All were audio-recorded, transcribed verbatim and data thematically analysed. Northern Oesophagogastric Unit, Royal Victoria Infirmary, Newcastle upon Tyne NHS Hospitals Foundation Trust. Patients with oesophagogastric cancer who participated in the ChemoFit intervention recruited between March 2020 and January 2021. A home-based physical activity and exercise intervention involving cardiovasular and strength exercise using resistance bands and pedometers to monitor step count. Weekly telephone calls provided feedback, support and positive reinforcement. Twenty-two participants (18 men, 4 women; aged 67±8 years old) took part in a focus group discussion (n=17) or a semi-structured interview (n=5). Fifteen themes were identified from the data generated. Participants reported that the intervention was physically and mentally beneficial, and data highlighted features of the intervention that influenced uptake and adherence. An opportunity to increase the likelihood of surviving the pending operation was reported by participants as the most salient factor to engagement, and using the intervention as a distraction from illness and taking steps to positively influence the situation were the most salient factors to adherence. Uptake to the ChemoFit intervention was encouraged by provision of information that participation could reduce surgical risk and that participants could play an active role in risk reduction. Adherence was facilitated by the intervention being considered a positive distraction and participants being able to do something that could ultimately provide benefit. While participants reported difficulties and avoidance with some of the exercises recommended, understanding the importance of physical activity and exercise as part of their treatment regimen led to individual adaptations to intervention components to reach individual goals. NCT04194463.

Identifiants

pubmed: 36137639
pii: bmjopen-2022-062526
doi: 10.1136/bmjopen-2022-062526
pmc: PMC9511537
doi:

Banques de données

ClinicalTrials.gov
['NCT04194463']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e062526

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Syst Rev. 2018 Jul 24;7(1):103
pubmed: 30041694
Environ Res. 2017 Oct;158:373-384
pubmed: 28686952
Anesthesiology. 2014 Nov;121(5):937-47
pubmed: 25076007
Cochrane Database Syst Rev. 2020 Jun 2;6:CD007568
pubmed: 32483832
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Eur J Surg Oncol. 2014 Nov;40(11):1421-8
pubmed: 24784775
Support Care Cancer. 2015 Aug;23(8):2311-8
pubmed: 25577502
Sports Med Open. 2019 Nov 27;5(1):45
pubmed: 31776701
N Engl J Med. 2006 Jul 6;355(1):11-20
pubmed: 16822992
Perioper Med (Lond). 2019 Dec 02;8:17
pubmed: 31827773
Ann Surg. 2016 Jul;264(1):47-53
pubmed: 26756766
Lancet. 2002 May 18;359(9319):1727-33
pubmed: 12049861
Disabil Rehabil. 2021 Apr;43(8):1084-1091
pubmed: 31411925
J Clin Nurs. 2013 Jan;22(1-2):4-21
pubmed: 23163239
Ann Surg. 2018 Jan;267(1):50-56
pubmed: 28489682
Surgery. 2011 Sep;150(3):505-14
pubmed: 21878237
Br J Anaesth. 2015 Feb;114(2):244-51
pubmed: 25274049
BMJ Open. 2020 Sep 21;10(9):e036382
pubmed: 32958484
J Community Health. 2013 Oct;38(5):976-93
pubmed: 23543372
Physiotherapy. 2014 Sep;100(3):196-207
pubmed: 24439570
Br J Surg. 2018 Jun;105(7):900-906
pubmed: 29601082
Support Care Cancer. 2018 Aug;26(8):2717-2723
pubmed: 29478189
Surg Oncol. 2018 Jun;27(2):289-298
pubmed: 29937184
BMJ. 2017 Aug 8;358:j3702
pubmed: 28790033
Int J Environ Health Res. 2005 Oct;15(5):319-37
pubmed: 16416750
Recent Results Cancer Res. 2011;186:367-87
pubmed: 21113773
J Rehabil Med. 2019 Oct 3;51(9):712-718
pubmed: 31468059
Eur J Surg Oncol. 2014 Oct;40(10):1313-20
pubmed: 24731268
Qual Life Res. 2019 Jul;28(7):1695-1703
pubmed: 30746588
Pilot Feasibility Stud. 2020 Apr 23;6:50
pubmed: 32346484
Health Educ Res. 2007 Dec;22(6):827-38
pubmed: 17272293

Auteurs

Matthew Cooper (M)

School of Health and life Sciences, Teesside University, Middlesbrough, UK.

Jakub Chmelo (J)

Northern Oesophagogastric Unit, Royal Victoria Infirmary, Newcastle upon Tyne, UK.

Rhona C F Sinclair (RCF)

Department of Anaesthesia and Critical Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Sarah Charman (S)

Cardiovascular Research Centre, Newcastle University, Newcastle, UK.

Kate Hallsworth (K)

Liver Unit, Freeman Hospital, Newcastle upon Tyne, UK.
Population Health Sciences Institute, Newcastle University Faculty of Medical Sciences, Newcastle upon Tyne, UK.

Jenny Welford (J)

Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Alexander W Phillips (AW)

School of Medical Education, Newcastle University, Newcastle upon Tyne, UK.

Alastair Greystoke (A)

Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Leah Avery (L)

School of Health and life Sciences, Teesside University, Middlesbrough, UK leah.avery@tees.ac.uk.
Population Health Sciences Institute, Newcastle University Faculty of Medical Sciences, Newcastle upon Tyne, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH